全文获取类型
收费全文 | 31652篇 |
免费 | 2425篇 |
国内免费 | 144篇 |
专业分类
耳鼻咽喉 | 321篇 |
儿科学 | 1022篇 |
妇产科学 | 773篇 |
基础医学 | 4558篇 |
口腔科学 | 674篇 |
临床医学 | 3447篇 |
内科学 | 6480篇 |
皮肤病学 | 750篇 |
神经病学 | 3260篇 |
特种医学 | 1121篇 |
外国民族医学 | 3篇 |
外科学 | 4096篇 |
综合类 | 290篇 |
一般理论 | 21篇 |
预防医学 | 2936篇 |
眼科学 | 486篇 |
药学 | 1821篇 |
1篇 | |
中国医学 | 55篇 |
肿瘤学 | 2106篇 |
出版年
2023年 | 302篇 |
2022年 | 231篇 |
2021年 | 1020篇 |
2020年 | 723篇 |
2019年 | 947篇 |
2018年 | 1069篇 |
2017年 | 836篇 |
2016年 | 883篇 |
2015年 | 946篇 |
2014年 | 1172篇 |
2013年 | 1521篇 |
2012年 | 2138篇 |
2011年 | 2284篇 |
2010年 | 1177篇 |
2009年 | 1106篇 |
2008年 | 1663篇 |
2007年 | 1780篇 |
2006年 | 1539篇 |
2005年 | 1505篇 |
2004年 | 1360篇 |
2003年 | 1271篇 |
2002年 | 1124篇 |
2001年 | 546篇 |
2000年 | 520篇 |
1999年 | 489篇 |
1998年 | 320篇 |
1997年 | 314篇 |
1996年 | 222篇 |
1995年 | 218篇 |
1994年 | 170篇 |
1993年 | 165篇 |
1992年 | 306篇 |
1991年 | 285篇 |
1990年 | 301篇 |
1989年 | 296篇 |
1988年 | 274篇 |
1987年 | 289篇 |
1986年 | 232篇 |
1985年 | 252篇 |
1984年 | 209篇 |
1983年 | 171篇 |
1982年 | 97篇 |
1981年 | 100篇 |
1980年 | 105篇 |
1979年 | 153篇 |
1978年 | 113篇 |
1977年 | 103篇 |
1974年 | 114篇 |
1973年 | 101篇 |
1972年 | 91篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
Jana Kristin Eckert Julia Kahle Andreas Bck Kathrin Zeber Kathrin Urner Wolfgang Greiner Simone Kreimeier Kirsten Beyer Josefine Dobbertin-Welsch Eckard Hamelmann Ines Gellhaus Christina Schorlemer Michael Kabesch Parastoo Kheiroddin Erika von Mutius Martin Depner Daniel Walter Gesine Hansen Stephanie DeStefano Sabine Schnadt Bianca Schaub 《Pediatric allergy and immunology》2022,33(1):e13652
2.
3.
Elvin S. Cheng Louiza S. Velentzis Marianne Weber Julia Steinberg Karen Canfell Xue Qin Yu 《International journal of cancer. Journal international du cancer》2023,152(12):2528-2540
There is growing, but inconsistent evidence suggesting oestrogen may play a key role in lung cancer development, especially among never-smoking women for whom lung cancer risk factors remain largely elusive. Using the China Kadoorie Biobank, a large-scale prospective cohort with 302 510 women aged 30 to 79 years recruited from 10 regions in China during 2004 to 2008, we assessed the risk of lung cancer death among self-reported never-smoking women who were cancer-free at baseline, in relation to age at menarche, age at menopause, time since menopause, prior use of oral contraceptives (OCP), number of livebirths, breastfeeding and age at first livebirth. Women were followed up to December 31, 2016 with linkage to mortality data. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox regression, adjusting for key confounders including several socio-demographic, environmental and lifestyle factors. Among 287 408 never-smoking women, 814 died from lung cancer with a median follow-up of 10.3 years. Women who had used OCP within 15 years prior to baseline had a significantly higher hazard of lung cancer death compared with never-users: HR = 1.85 (95% CI: 1.14-3.00) and risk increased by 6% with each additional year of use: HR = 1.06 (1.01-1.10). Among parous women, the hazard of lung cancer death increased by 13% with each single livebirth: HR = 1.13 (1.05-1.23); and among post-menopausal women, the risk increased by 2% with each year since menopause: HR = 1.02 (1.01-1.04). These results suggest that reproductive factors which were proxies for lower endogenous oestrogen level, for example, longer duration of OCP use, could play a role in lung cancer development. 相似文献
4.
Boothe Emily Olenderek Marta Noyola M. Cristina Rushing Julia Allred Erinn Kaplan Sebastian 《Zeitschrift fur Gesundheitswissenschaften》2022,30(6):1373-1380
Journal of Public Health - Group prenatal care provides an alternative model of prenatal care that allows for collaboration with peers, education, discussion, and self-management training in... 相似文献
5.
Chopard Romain Campia Umberto Morin Lucas Jering Karola S. Almarzooq Zaid I. Snyder Julia Elizabeth Rizzo Samantha Waxman Aaron B. Goldhaber Samuel Z. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(3):449-460
Journal of Thrombosis and Thrombolysis - Multidisciplinary pulmonary embolism (PE) response teams have garnered widespread adoption given the complexities of managing acute PE and provide a... 相似文献
6.
Anand Rajan Peerapol Wangrattanapranee Jonathan Kessler Trilokesh Dey Kidambi James H Tabibian 《World journal of gastrointestinal surgery》2022,14(4):286-303
Gastrostomy tube placement is a procedure that achieves enteral access for nutrition, decompression, and medication administration. Preprocedural evaluation and selection of patients is necessary to provide optimal benefit and reduce the risk of adverse events (AEs). Appropriate indications, contraindications, ethical considerations, and comorbidities of patients referred for gastrostomy placement should be weighed and balanced. Additionally, endoscopist should consider either a transoral or transabdominal approach is appropriate, and radiologic or surgical gastrostomy tube placement is needed. However, medical history, physical examination, and imaging prior to the procedure should be considered to tailor the appropriate approach and reduce the risk of AEs. 相似文献
7.
8.
9.
10.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献